J Perinat Neonatal Nurs. 2025 Jan-Mar 01;39(1):45-53. doi: 10.1097/JPN.0000000000000816. Epub 2025 Jan 29.
ABSTRACT
PURPOSE: This study was aimed to assess the effect of intermittent fetal heart rate (FHR) monitoring using Moyo Doppler compared with fetoscope in hospitals of Ethiopia, 2023.
BACKGROUND: To facilitate more prompt identification of a hypoxic fetus, Laerdal Global Health has recently introduced the Moyo FHR monitor. Nevertheless, there exists limited knowledge regarding its efficacy derived from multicenter contextual trials conducted in resource-constrained environments, specifically in Ethiopia.
METHODS: This randomized trial (PACTR202305607000259) enrolled 2518 low-risk laboring women in the study during the study period, using a simple randomization technique from September 28, 2022, to February 28, 2023. A total of 1259 and 1259 were followed by Moyo and Pinard fetoscope, respectively. A P-value of less than .05 was considered significant.
RESULTS: The abnormal FHR was detected among 60 women (5.1%) and 30 women (2.4%) (P = .001) in the Moyo and Pinard fetoscope arms, respectively.
CONCLUSION: The Moyo FHR monitor has demonstrated efficacy in detecting abnormal FHRs when compared with the Pinard fetoscope.
IMPLICATIONS FOR PRACTICE AND RESEARCH: It is recommended that healthcare systems in low-resource settings consider implementing the Moyo device for FHR monitoring.
PMID:39883112 | DOI:10.1097/JPN.0000000000000816